These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26512750)

  • 1. Prolactin as an Adjunct for Type 1 Diabetes Immunotherapy.
    Hyslop CM; Tsai S; Shrivastava V; Santamaria P; Huang C
    Endocrinology; 2016 Jan; 157(1):150-65. PubMed ID: 26512750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin: An Effective Partner for Anti-CD3 in Treating Type 1 Diabetes.
    Xiao X
    Endocrinology; 2016 Jan; 157(1):39-41. PubMed ID: 26717470
    [No Abstract]   [Full Text] [Related]  

  • 3. Oligofructose as an adjunct in treatment of diabetes in NOD mice.
    Chan C; Hyslop CM; Shrivastava V; Ochoa A; Reimer RA; Huang C
    Sci Rep; 2016 Nov; 6():37627. PubMed ID: 27874076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice.
    Besançon A; Goncalves T; Valette F; Dahllöf MS; Mandrup-Poulsen T; Chatenoud L; You S
    Diabetologia; 2018 Feb; 61(2):389-398. PubMed ID: 29030662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal Delivery of Proinsulin and IL-10 via
    Cook DP; Cunha JPMCM; Martens PJ; Sassi G; Mancarella F; Ventriglia G; Sebastiani G; Vanherwegen AS; Atkinson MA; Van Huynegem K; Steidler L; Caluwaerts S; Rottiers P; Teyton L; Dotta F; Gysemans C; Mathieu C
    Front Immunol; 2020; 11():1103. PubMed ID: 32582188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells.
    Sherry NA; Chen W; Kushner JA; Glandt M; Tang Q; Tsai S; Santamaria P; Bluestone JA; Brillantes AM; Herold KC
    Endocrinology; 2007 Nov; 148(11):5136-44. PubMed ID: 17673522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ghrelin mitigates β-cell mass loss during insulitis in an animal model of autoimmune diabetes mellitus, the BioBreeding/Worcester rat.
    Baena-Nieto G; Lomas-Romero IM; Mateos RM; Leal-Cosme N; Perez-Arana G; Aguilar-Diosdado M; Segundo C; Lechuga-Sancho AM
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27103341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.
    Reddy S; Cheung CC; Chai RC; Rodrigues JA
    Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceleration of autoimmune diabetes in Rheb-congenic NOD mice with β-cell-specific mTORC1 activation.
    Sasaki H; Yasuda H; Moriyama H; Nakamura A; Shimizu M; Arai T; Nagata M; Hara K; Yokono K
    Biochem Biophys Res Commun; 2011 May; 408(2):306-11. PubMed ID: 21513702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exendin-4 treatment of nonobese diabetic mice increases beta-cell proliferation and fractional insulin reactive area.
    Xue S; Wasserfall C; Parker M; McGrail S; McGrail K; Campbell-Thompson M; Schatz DA; Atkinson MA; Haller MJ
    J Diabetes Complications; 2010; 24(3):163-7. PubMed ID: 19217320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining MK626, a novel DPP-4 inhibitor, and low-dose monoclonal CD3 antibody for stable remission of new-onset diabetes in mice.
    Ding L; Gysemans CA; Stangé G; Heremans Y; Yuchi Y; Takiishi T; Korf H; Chintinne M; Carr RD; Heimberg H; Pipeleers D; Mathieu C
    PLoS One; 2014; 9(9):e107935. PubMed ID: 25268801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biphasic decline of β-cell function with age in euglycemic nonobese diabetic mice parallels diabetes onset.
    Cechin SR; Lopez-Ocejo O; Karpinsky-Semper D; Buchwald P
    IUBMB Life; 2015 Aug; 67(8):634-44. PubMed ID: 26099053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
    Bergerot I; Fabien N; Thivolet C
    Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming.
    Villalba A; Rodriguez-Fernandez S; Perna-Barrull D; Ampudia RM; Gomez-Muñoz L; Pujol-Autonell I; Aguilera E; Coma M; Cano-Sarabia M; Vázquez F; Verdaguer J; Vives-Pi M
    Front Endocrinol (Lausanne); 2020; 11():258. PubMed ID: 32477262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Pathogenesis of Autoimmune Diabetes in Humans, NOD Mice, and Canines: Has a Valuable Animal Model of Type 1 Diabetes Been Overlooked?
    O'Kell AL; Wasserfall C; Catchpole B; Davison LJ; Hess RS; Kushner JA; Atkinson MA
    Diabetes; 2017 Jun; 66(6):1443-1452. PubMed ID: 28533295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta Cell Mass Restoration in Alloxan-Diabetic Mice Treated with EGF and Gastrin.
    Song I; Patel O; Himpe E; Muller CJ; Bouwens L
    PLoS One; 2015; 10(10):e0140148. PubMed ID: 26452142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice.
    Gagliani N; Jofra T; Posgai AL; Atkinson MA; Battaglia M
    PLoS One; 2015; 10(11):e0142318. PubMed ID: 26580221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin protects against diabetes induced by multiple low doses of streptozotocin in mice.
    Holstad M; Sandler S
    J Endocrinol; 1999 Nov; 163(2):229-34. PubMed ID: 10556772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant immunotherapy increases beta cell regenerative factor Reg2 in the pancreas of diabetic mice.
    Huszarik K; Wright B; Keller C; Nikoopour E; Krougly O; Lee-Chan E; Qin HY; Cameron MJ; Gurr WK; Hill DJ; Sherwin RS; Kelvin DJ; Singh B
    J Immunol; 2010 Nov; 185(9):5120-9. PubMed ID: 20876350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.